Analyst
B. Riley Securities
Equibles does not estimate personal net worth.
Mayank Montani is recorded as Analyst at B. Riley Securities. Mayank Montani has spoken on 2 earnings calls across 2 companies, most recently for Vaxart, Inc. on March 12, 2026. Those appearances were for Vaxart, Inc. (VXRT) and Agenus Inc (AGEN). The companies whose calls Mayank Montani spoke on are classified in the Healthcare sector.
“So first on the COVID program, now you obviously have multiple parties here, very serious, you know, vaccine parties here, MARDA and also Sanofi after change of control.”
“Does that address your question, Mark? uh yes i guess the type b uh meeting focus i i heard that it's going to be primarily crc focused is that fair and and having those two indications lakeline and uh and new adjuvant yeah that's clear i guess uh are you able to comment on when do you expect the type b meeting to…”
B. Riley Securities
Analyst
Transcript header (unverified)
VXRT
Biotechnology · Healthcare
AGEN
Biotechnology · Healthcare
